Loading…

Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort

ABSTRACT Postmenopausal osteoporosis is characterized by the occurrence of fragility fracture with an increase in morbidity and mortality. Recently, microRNAs (miRNAs) have raised interest as regulators of translational repression, mediating a number of key processes, including bone tissue in both p...

Full description

Saved in:
Bibliographic Details
Published in:Journal of bone and mineral research 2019-06, Vol.34 (6), p.1074-1085
Main Authors: Feurer, Elodie, Kan, Casina, Croset, Martine, Sornay‐Rendu, Elisabeth, Chapurlat, Roland
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533
cites cdi_FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533
container_end_page 1085
container_issue 6
container_start_page 1074
container_title Journal of bone and mineral research
container_volume 34
creator Feurer, Elodie
Kan, Casina
Croset, Martine
Sornay‐Rendu, Elisabeth
Chapurlat, Roland
description ABSTRACT Postmenopausal osteoporosis is characterized by the occurrence of fragility fracture with an increase in morbidity and mortality. Recently, microRNAs (miRNAs) have raised interest as regulators of translational repression, mediating a number of key processes, including bone tissue in both physiological and diseased states. The aim of this study was to examine the serum levels of 32 preselected miRNAs with reported function in bone and their association with osteoporotic fracture. We performed cross‐sectional and longitudinal analyses from the OFELY Cohort. Serum levels of the miRNAs were quantified by qRT‐PCR in 682 women: 99 premenopausal and 583 postmenopausal women, with 1 and 122 women with prevalent fragility fractures in each group, respectively. We have collected clinical variables (such as age, prevalent, and incident fractures), bone turnover markers (BTMs), BMD by dual X‐ray absorptiometry, and bone microarchitecture with HRpQCT. We observed a number of miRNAs to be associated with fragility fractures (prevalent or incident), BTMs, BMD, and microarchitecture. This effect, however, was negated after age adjustment. This may be because age was also strongly associated with the serum levels of the 32 miRNAs (correlation coefficient up to 0.49), confirming previous findings. In conclusion, in a well‐characterized prospective cohort with a sizeable sample size, we found no evidence that these 32 preselected miRNAs were not associated with BTMs, BMD, microarchitecture, and or fragility fractures. © 2019 American Society for Bone and Mineral Research.
doi_str_mv 10.1002/jbmr.3685
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2188205795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2188205795</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533</originalsourceid><addsrcrecordid>eNp1kU1vEzEQhi1ERUPhwB9AlriA1G299vqLWxKaFpRSqZQDJ2vizNINu-ti71L67-s0hQMSl_nQPHo1My8hr0p2VDLGjzerLh4JZeQTMiklF0WlTPmUTJgxVcEqUe6T5yltGGNKKvWM7AtmBLOaT8jvJfgfNNR0mlLwDQxN6OkMh1vEnn7BFv1A5030Y5tH_XfaNZefp4lCv6az0CM9h5QO6dUY-_AL4-HDYBHBD2PE9J5-gAFyHzo6XCO9WJwsv9F5uA5xeEH2amgTvnzMB-Tr4uRqflYsL04_zqfLwgtjZAFW6xUDqJXKhYCq1rxGu66tVdqUK6UU4Np68GCRWwRW6Ry8kFrLWgpxQN7udG9i-DliGlzXJI9tCz2GMTleGsOZ1FZm9M0_6Cbkw_J2jnMlpeJGqEy921E-hpQi1u4mNh3EO1cyt7XDbe1wWzsy-_pRcVx1uP5L_vl_Bo53wG3T4t3_ldyn2fnlg-Q9F8WTaQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2265562836</pqid></control><display><type>article</type><title>Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort</title><source>Oxford Journals Online</source><creator>Feurer, Elodie ; Kan, Casina ; Croset, Martine ; Sornay‐Rendu, Elisabeth ; Chapurlat, Roland</creator><creatorcontrib>Feurer, Elodie ; Kan, Casina ; Croset, Martine ; Sornay‐Rendu, Elisabeth ; Chapurlat, Roland</creatorcontrib><description>ABSTRACT Postmenopausal osteoporosis is characterized by the occurrence of fragility fracture with an increase in morbidity and mortality. Recently, microRNAs (miRNAs) have raised interest as regulators of translational repression, mediating a number of key processes, including bone tissue in both physiological and diseased states. The aim of this study was to examine the serum levels of 32 preselected miRNAs with reported function in bone and their association with osteoporotic fracture. We performed cross‐sectional and longitudinal analyses from the OFELY Cohort. Serum levels of the miRNAs were quantified by qRT‐PCR in 682 women: 99 premenopausal and 583 postmenopausal women, with 1 and 122 women with prevalent fragility fractures in each group, respectively. We have collected clinical variables (such as age, prevalent, and incident fractures), bone turnover markers (BTMs), BMD by dual X‐ray absorptiometry, and bone microarchitecture with HRpQCT. We observed a number of miRNAs to be associated with fragility fractures (prevalent or incident), BTMs, BMD, and microarchitecture. This effect, however, was negated after age adjustment. This may be because age was also strongly associated with the serum levels of the 32 miRNAs (correlation coefficient up to 0.49), confirming previous findings. In conclusion, in a well‐characterized prospective cohort with a sizeable sample size, we found no evidence that these 32 preselected miRNAs were not associated with BTMs, BMD, microarchitecture, and or fragility fractures. © 2019 American Society for Bone and Mineral Research.</description><identifier>ISSN: 0884-0431</identifier><identifier>EISSN: 1523-4681</identifier><identifier>DOI: 10.1002/jbmr.3685</identifier><identifier>PMID: 30830972</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Absorptiometry ; Age ; AGING ; Bone mass ; BONE QCT/MICROCT ; Bone turnover ; DISEASES AND DISORDERS OF/RELATED TO BONE ; DXA ; Fractures ; Hormone replacement therapy ; miRNA ; Morbidity ; OSTEOPOROSIS ; Post-menopause ; Serum levels</subject><ispartof>Journal of bone and mineral research, 2019-06, Vol.34 (6), p.1074-1085</ispartof><rights>2019 American Society for Bone and Mineral Research</rights><rights>2019 American Society for Bone and Mineral Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533</citedby><cites>FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30830972$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feurer, Elodie</creatorcontrib><creatorcontrib>Kan, Casina</creatorcontrib><creatorcontrib>Croset, Martine</creatorcontrib><creatorcontrib>Sornay‐Rendu, Elisabeth</creatorcontrib><creatorcontrib>Chapurlat, Roland</creatorcontrib><title>Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort</title><title>Journal of bone and mineral research</title><addtitle>J Bone Miner Res</addtitle><description>ABSTRACT Postmenopausal osteoporosis is characterized by the occurrence of fragility fracture with an increase in morbidity and mortality. Recently, microRNAs (miRNAs) have raised interest as regulators of translational repression, mediating a number of key processes, including bone tissue in both physiological and diseased states. The aim of this study was to examine the serum levels of 32 preselected miRNAs with reported function in bone and their association with osteoporotic fracture. We performed cross‐sectional and longitudinal analyses from the OFELY Cohort. Serum levels of the miRNAs were quantified by qRT‐PCR in 682 women: 99 premenopausal and 583 postmenopausal women, with 1 and 122 women with prevalent fragility fractures in each group, respectively. We have collected clinical variables (such as age, prevalent, and incident fractures), bone turnover markers (BTMs), BMD by dual X‐ray absorptiometry, and bone microarchitecture with HRpQCT. We observed a number of miRNAs to be associated with fragility fractures (prevalent or incident), BTMs, BMD, and microarchitecture. This effect, however, was negated after age adjustment. This may be because age was also strongly associated with the serum levels of the 32 miRNAs (correlation coefficient up to 0.49), confirming previous findings. In conclusion, in a well‐characterized prospective cohort with a sizeable sample size, we found no evidence that these 32 preselected miRNAs were not associated with BTMs, BMD, microarchitecture, and or fragility fractures. © 2019 American Society for Bone and Mineral Research.</description><subject>Absorptiometry</subject><subject>Age</subject><subject>AGING</subject><subject>Bone mass</subject><subject>BONE QCT/MICROCT</subject><subject>Bone turnover</subject><subject>DISEASES AND DISORDERS OF/RELATED TO BONE</subject><subject>DXA</subject><subject>Fractures</subject><subject>Hormone replacement therapy</subject><subject>miRNA</subject><subject>Morbidity</subject><subject>OSTEOPOROSIS</subject><subject>Post-menopause</subject><subject>Serum levels</subject><issn>0884-0431</issn><issn>1523-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kU1vEzEQhi1ERUPhwB9AlriA1G299vqLWxKaFpRSqZQDJ2vizNINu-ti71L67-s0hQMSl_nQPHo1My8hr0p2VDLGjzerLh4JZeQTMiklF0WlTPmUTJgxVcEqUe6T5yltGGNKKvWM7AtmBLOaT8jvJfgfNNR0mlLwDQxN6OkMh1vEnn7BFv1A5030Y5tH_XfaNZefp4lCv6az0CM9h5QO6dUY-_AL4-HDYBHBD2PE9J5-gAFyHzo6XCO9WJwsv9F5uA5xeEH2amgTvnzMB-Tr4uRqflYsL04_zqfLwgtjZAFW6xUDqJXKhYCq1rxGu66tVdqUK6UU4Np68GCRWwRW6Ry8kFrLWgpxQN7udG9i-DliGlzXJI9tCz2GMTleGsOZ1FZm9M0_6Cbkw_J2jnMlpeJGqEy921E-hpQi1u4mNh3EO1cyt7XDbe1wWzsy-_pRcVx1uP5L_vl_Bo53wG3T4t3_ldyn2fnlg-Q9F8WTaQ</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Feurer, Elodie</creator><creator>Kan, Casina</creator><creator>Croset, Martine</creator><creator>Sornay‐Rendu, Elisabeth</creator><creator>Chapurlat, Roland</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201906</creationdate><title>Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort</title><author>Feurer, Elodie ; Kan, Casina ; Croset, Martine ; Sornay‐Rendu, Elisabeth ; Chapurlat, Roland</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Absorptiometry</topic><topic>Age</topic><topic>AGING</topic><topic>Bone mass</topic><topic>BONE QCT/MICROCT</topic><topic>Bone turnover</topic><topic>DISEASES AND DISORDERS OF/RELATED TO BONE</topic><topic>DXA</topic><topic>Fractures</topic><topic>Hormone replacement therapy</topic><topic>miRNA</topic><topic>Morbidity</topic><topic>OSTEOPOROSIS</topic><topic>Post-menopause</topic><topic>Serum levels</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feurer, Elodie</creatorcontrib><creatorcontrib>Kan, Casina</creatorcontrib><creatorcontrib>Croset, Martine</creatorcontrib><creatorcontrib>Sornay‐Rendu, Elisabeth</creatorcontrib><creatorcontrib>Chapurlat, Roland</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of bone and mineral research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feurer, Elodie</au><au>Kan, Casina</au><au>Croset, Martine</au><au>Sornay‐Rendu, Elisabeth</au><au>Chapurlat, Roland</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort</atitle><jtitle>Journal of bone and mineral research</jtitle><addtitle>J Bone Miner Res</addtitle><date>2019-06</date><risdate>2019</risdate><volume>34</volume><issue>6</issue><spage>1074</spage><epage>1085</epage><pages>1074-1085</pages><issn>0884-0431</issn><eissn>1523-4681</eissn><abstract>ABSTRACT Postmenopausal osteoporosis is characterized by the occurrence of fragility fracture with an increase in morbidity and mortality. Recently, microRNAs (miRNAs) have raised interest as regulators of translational repression, mediating a number of key processes, including bone tissue in both physiological and diseased states. The aim of this study was to examine the serum levels of 32 preselected miRNAs with reported function in bone and their association with osteoporotic fracture. We performed cross‐sectional and longitudinal analyses from the OFELY Cohort. Serum levels of the miRNAs were quantified by qRT‐PCR in 682 women: 99 premenopausal and 583 postmenopausal women, with 1 and 122 women with prevalent fragility fractures in each group, respectively. We have collected clinical variables (such as age, prevalent, and incident fractures), bone turnover markers (BTMs), BMD by dual X‐ray absorptiometry, and bone microarchitecture with HRpQCT. We observed a number of miRNAs to be associated with fragility fractures (prevalent or incident), BTMs, BMD, and microarchitecture. This effect, however, was negated after age adjustment. This may be because age was also strongly associated with the serum levels of the 32 miRNAs (correlation coefficient up to 0.49), confirming previous findings. In conclusion, in a well‐characterized prospective cohort with a sizeable sample size, we found no evidence that these 32 preselected miRNAs were not associated with BTMs, BMD, microarchitecture, and or fragility fractures. © 2019 American Society for Bone and Mineral Research.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30830972</pmid><doi>10.1002/jbmr.3685</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0884-0431
ispartof Journal of bone and mineral research, 2019-06, Vol.34 (6), p.1074-1085
issn 0884-0431
1523-4681
language eng
recordid cdi_proquest_miscellaneous_2188205795
source Oxford Journals Online
subjects Absorptiometry
Age
AGING
Bone mass
BONE QCT/MICROCT
Bone turnover
DISEASES AND DISORDERS OF/RELATED TO BONE
DXA
Fractures
Hormone replacement therapy
miRNA
Morbidity
OSTEOPOROSIS
Post-menopause
Serum levels
title Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T11%3A59%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lack%20of%20Association%20Between%20Select%20Circulating%20miRNAs%20and%20Bone%20Mass,%20Turnover,%20and%20Fractures:%20Data%20From%20the%20OFELY%20Cohort&rft.jtitle=Journal%20of%20bone%20and%20mineral%20research&rft.au=Feurer,%20Elodie&rft.date=2019-06&rft.volume=34&rft.issue=6&rft.spage=1074&rft.epage=1085&rft.pages=1074-1085&rft.issn=0884-0431&rft.eissn=1523-4681&rft_id=info:doi/10.1002/jbmr.3685&rft_dat=%3Cproquest_cross%3E2188205795%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3885-a977b0aaf6677b3a4f72fe9df996781b666aed9caca9e29ea047ea0c35775f533%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2265562836&rft_id=info:pmid/30830972&rfr_iscdi=true